Home > Insider Trading > Filing (0001209191-10-024067)

Filing Details

Accession Number:: 0001209191-10-024067
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2010-04-28 13:00:00
Reporting Period:: 2010-04-27

Filing Date:: 2010-04-28
Accepted Time:: 2010-04-28 17:53:12
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1267602	Alimera Sciences Inc	ALIM	Pharmaceutical Preparations (2834)	000000000

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1424875	J Mark Brooks	950 Tower Lane, Suite 700 Foster City CA 94404		Yes	No	Yes	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Acquisiton	2010-04-27	1,649,358	$0.00	1,649,358	No	4	C	Indirect	See FN
Common Stock	Acquisiton	2010-04-27	1,121,866	$0.00	2,771,224	No	4	C	Indirect	See FN
Common Stock	Acquisiton	2010-04-27	1,153,719	$0.00	3,924,943	No	4	C	Indirect	See FN
Common Stock	Acquisiton	2010-04-27	574,515	$0.00	4,499,458	No	4	C	Indirect	See FN
Common Stock	Acquisiton	2010-04-27	363,636	$11.00	4,863,094	No	4	P	Indirect	See FN

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	C	Indirect	See FN
No	4	C	Indirect	See FN
No	4	C	Indirect	See FN
No	4	C	Indirect	See FN
No	4	P	Indirect	See FN

Reported Derivative Transactions

Show Other Fields >>

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Series A Convertible Preferred Stock	Disposition	2010-04-27	1,562,184	$0.00	1,649,358	$0.00
Common Stock	Series B Convertible Preferred Stock	Disposition	2010-04-27	1,121,866	$0.00	1,121,866	$0.00
Common Stock	Series C Convertible Preferred Stock	Disposition	2010-04-27	1,153,719	$0.00	1,153,719	$0.00
Common Stock	Series C-1 Convertible Preferred Stock	Disposition	2010-04-27	574,515	$0.00	574,515	$0.00
Common Stock	Stock Option (Right to Buy)	Acquisiton	2010-04-27	7,500	$0.00	7,500	$11.00

Remaning Holdings	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
0		No	4	C	Indirect
0		No	4	C	Indirect
0		No	4	C	Indirect
0		No	4	C	Indirect
7,500	2020-04-26	No	4	A	Direct

Footnotes

Automatic conversion, in connection with the Issuer's initial public offering, of 1,562,184 shares of Series A Preferred Stock into 1,649,358 shares of common stock.
The shares are held by BAVP, LP ("BAVP"). The General Partner of BAVP is Scale Venture Management I, LLC ("Scale"). The Reporting Person is a managing member of Scale and shares voting and investment power with respect to these shares with three other managing members of Scale. The Reporting Person disclaims beneficial ownership with respect to these shares except to the extent of his pecuniary interest therein.
Automatic conversion, in connection with the Issuer's initial public offering, of Series B Preferred Stock at a rate of 1-for-1, resulting in the issuance of 1,121,866 shares of common stock.
The Series B Convertible Preferred Stock converted into the Issuer's Common Stock at a rate of 1-for-1.
Automatic conversion, in connection with the Issuer's initial public offering, of Series C Preferred Stock at a rate of 1-for-1, resulting in the issuance of 1,153,719 shares of common stock.
The Series C Convertible Preferred Stock converted into the Issuer's Common Stock at a rate of 1-for-1.
Automatic conversion, in connection with the Issuer's initial public offering, of Series C-1 Preferred Stock at a rate of 1-for-1, resulting in the issuance of 574,515 shares of common stock.
The Series C-1 Convertible Preferred Stock converted into the Issuer's Common Stock at a rate of 1-for-1.
The securities are preferred stock of the Issuer and do not have an expiration date. The securities automatically converted into common stock upon the closing of the Issuer's initial public offering.
The shares subject to the option vest and become exercisable at a rate of 25% on the first anniversary of the the vesting commencement date, and the remainder vest and become exercisable in equal monthly installments over the following 36 months.